FDA Investigator

Alifiya H Ghadiali

Latest inspection on record: Harmans, United States, April 2025 · records back to 2022

Biologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 8 inspections across 8 sites are on record.
  • 0 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2025-04-28.

At a glance

Inspections

8

Sites

8

Observations

0

Career since

Aug 2022

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Catalent Maryland Inc28 Apr 2025BiologicsOn file
Vgxi Inc25 Nov 2024BiologicsOn file
Aspen Notre Dame de Bondeville7 Jun 2024Biologics
Miltenyi Biotec, Inc3 May 2024BiologicsOn file
Humacyte Global, Inc5 Apr 2024BiologicsOn file

Sites inspected

Catalent Maryland IncHarmans, United States1 insp.
Vgxi IncThe Woodlands, United States1 insp.
Aspen Notre Dame de BondevilleNotre-Dame-De-Bondeville, France1 insp.
Miltenyi Biotec, IncGaithersburg, United States1 insp.
Humacyte Global, IncDurham, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Sarah E Underwood1 shared
Ou Ma1 shared
Y N Nguyen1 shared
Jin S Hong1 shared
Alan G Baer1 shared

Full investigator report

Get the verbatim findings behind Alifiya H Ghadiali's inspection record

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site